In conclusion, HMP1G NPs downregulated tumor‐derived IDO1 the AhR/STAT3/IL axis, improving KYN/TRP metabolism dysregulation, effectively overcoming metabolic immune suppression within the TME, reversing immunological tolerance in cold tumors, and sensitizing tumor cells to ICB therapy. Here, AHR is linked to neoplasm.